Skip to main content

With cancer-testing telehealth platform on track for Q1 launch, stage zero shareholders await Covid-19 testing-related revenue results

By investorintel.com  
   February 07, 2021

With its planned rollout of Aristotle, StageZero has built a fully integrated telehealth platform that supports its cancer diagnostics program. With the current stay-at-home orders imposed by governments, telehealth has emerged as a viable alternative to access health care and diagnostic services.

Full story


Get the latest on healthcare leadership in your inbox.